May 9th 2024
A new analysis found triple therapy for COPD, particularly B/G/F, more cost-effective vs dual therapy in terms of exacerbations and quality-adjusted life years.
Still Rx'ing Antibiotics for Bronchitis and Non–Group A Strep Sore Throat
October 7th 2013This is an opportunity for primary care to help avert a public health catastrophe. Physicians need to take ownership over this issue and demand more time for URI patients-E&M criteria do not capture what is lost when these visits are viewed simply as “Level 2 Office Visit, CPT 99212.”